A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim (TMP)-sulfamethoxazole (SMX) treatment.
cervical lymphadenopathy
SMX
cervical lymphadenopathy
sulfamethoxazole
hepatosplenomegaly
SMX
skin eruptions
trimethoprim
hepatosplenomegaly
trimethoprim
atypical lymphocytosis
sulfamethoxazole
eosinophilia
TMP
eosinophilia
SMX
cervical lymphadenopathy
trimethoprim
fever
SMX
eosinophilia
trimethoprim
skin eruptions
SMX
hepatosplenomegaly
sulfamethoxazole
fever
sulfamethoxazole
eosinophilia
sulfamethoxazole
atypical lymphocytosis
SMX
atypical lymphocytosis
TMP
skin eruptions
sulfamethoxazole
fever
TMP
fever
trimethoprim
cervical lymphadenopathy
TMP
skin eruptions
TMP
atypical lymphocytosis
trimethoprim
hepatosplenomegaly
TMP